Take our TMF Risk Score Survey today!
Thursday, October 29, 2015 | 3:00 PM
NEW YORK, October 29, 2015 – TransPerfect, the world’s largest privately held provider of language and technology solutions for global business, today announced Q3 revenues of nearly $130 million, the highest total for this period in the company’s history and more than $10 million ahead of last year’s total for the same quarter.
The company’s strong performance in the third quarter marks a continuation of the torrid growth pace that has already produced record highs for total sales in Q1 and Q2 of this year. Year-to-date, revenues are more than $27 million ahead of 2014’s pace.
Growth in the company’s GlobalLink technology division has continued to quicken, with over 500 new companies choosing GlobalLink technology solutions to manage their multilingual content and website localization initiatives this year alone.
Also contributing to the company’s results is the high number of retailers and e-commerce organizations preparing for the upcoming holiday shopping season, as well as strategic multilingual initiatives within finance, manufacturing, and life sciences organizations.
“The dedication and talent of our employees continues to amaze me every single day,” said Liz Elting, Co-CEO of TransPerfect. “Seeing the incredible things they do for the benefit of our clients and for each other is truly inspiring, and it is at the center of our success as an organization.”
“Setting a new revenue record is a major accomplishment,” added Co-CEO Phil Shawe. “But what’s even better is that our growth has been coming from multiple divisions of the company. I would like to thank both our clients and our long-tenured management team who are responsible for this success.”
About Trial Interactive
TransPerfect’s Trial Interactive solution provides a collaborative, web-based platform for clinical development that enables sponsors, CROs, IRBs, and other vendors to maintain and update clinical trial documentation in a secure online environment, adhering to global regulatory requirements. With fully searchable solutions including investigator portals, Trial Interactive streamlines study timelines and reduces the administrative burdens of global clinical trials. As part of TransPerfect’s Life Sciences division, Trial Interactive is dedicated to working with clients on a global, collaborative level, supporting a wide range of requirements including e-feasibility, study start-up, eTMF review/reconciliation, mobile applications, learning management and document management systems, investigator portals, pharmacovigilance and safety management, and endpoint adjudication. For more information on Trial Interactive, please contact firstname.lastname@example.org or +1 212.400.8848, or visit www.trialinteractive.com.
TransPerfect is the world’s largest provider of language services and technology solutions for global business. From offices in over 90 cities on six continents, TransPerfect offers a full range of services in 170+ languages to clients worldwide. More than 4,000 global organizations employ TransPerfect’s GlobalLink® Product Suite to simplify management of multilingual content. With an unparalleled commitment to quality and client service, TransPerfect is fully ISO 9001 and ISO 17100 certified. TransPerfect has global headquarters in New York, with regional headquarters in London and Hong Kong. For more information, please visit our website at www.transperfect.com.